3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiBrog, AM; Kern, KA; Mietlicki-Baase, EG; Mukherjee, A; Przybysz, JT | 1 |
| Blobner, M; Jeevendra Martyn, JA; Kem, WR; Khan, MAS; Lewald, H; Nagashima, M; Sasakawa, T; Schaller, SJ; Schlegel, J; Schneider, G; Schönfelder, M; Schulz, F | 1 |
2 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Body Weight
| Article | Year |
|---|---|
The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 does not affect food intake in rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Body Weight; Eating; Glucagon-Like Peptide 1; Male; Mice; Pyridines; Rats; Rats, Sprague-Dawley | 2022 |
GTS-21 attenuates loss of body mass, muscle mass, and function in rats having systemic inflammation with and without disuse atrophy.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Body Weight; Corynebacterium Infections; Immobilization; Male; Methemoglobin; Muscle, Skeletal; Muscular Atrophy; Nicotinic Agonists; Pyridines; Rats; Rats, Sprague-Dawley; Systemic Inflammatory Response Syndrome | 2018 |